SCHEMBL7094871

SCHEMBL7094871

O/N=C/c1ccc(O)c(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.71
BLM P54132 4/20 0.71
L3MBTL1 Q9Y468 4/20 0.71
ALPL P05186 2/20 0.71
ALPI P09923 2/20 0.71
ALPG P10696 2/20 0.71
GFER P55789 2/20 0.71
SRC P12931 1/20 0.59
LCK P06239 3/20 0.58
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
KDM4E B2RXH2 4/20 0.57
ALDH1A1 P00352 3/20 0.57
CYP1A2 P05177 2/20 0.57
LMNA P02545 2/20 0.57
TP53 P04637 2/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
ALOX15 P16050 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1070078 1.00 POLB (0.71) POLBBLML3MBTL1ALPLALPI
SCHEMBL1070076 1.00 POLB (0.71) POLBBLML3MBTL1ALPLALPI
SCHEMBL15951399 0.83 POLB (1.00) POLBBLML3MBTL1ALPLALPI
SCHEMBL17548931 0.80 L3MBTL1 (0.47) POLBBLML3MBTL1ALPLALPI
SCHEMBL28765452 0.80 L3MBTL1 (0.47) POLBBLML3MBTL1ALPLALPI
SCHEMBL17548936 0.80 LMNA (0.49) POLBBLML3MBTL1ALPLALPI
SCHEMBL17329459 0.80 L3MBTL1 (0.52) POLBBLML3MBTL1ALPLALPI
SCHEMBL17329458 0.80 L3MBTL1 (0.52) POLBBLML3MBTL1ALPLALPI
SCHEMBL23067460 0.79 POLB (0.68) POLBBLML3MBTL1ALPLALPI
SCHEMBL29557130 0.79 POLB (0.68) POLBBLML3MBTL1ALPLALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110714213-A Cyanide-free alkaline cuprous copper electroplating complexing agent 武汉奥邦表面技术有限公司 2020-01-21 CN claimed
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-03-13 US claimed
CN-109310649-B Dihydrochalcone derivatives affecting inflammatory states 西姆莱斯有限公司 2021-06-29 CN disclosed
CN-107118128-B Preparation method of 3, 4-dihydroxy benzonitrile 常州佳德医药科技有限公司 2020-04-21 CN disclosed
US-10174033-B2 N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2019-01-08 US disclosed
EP-3142752-B1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2018-06-20 EP disclosed
EP-3142752-B1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2018-06-20 EP disclosed
US-9828335-B2 Nitrone compounds and their use in personal care DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-28 US disclosed
US-9828335-B2 Nitrone compounds and their use in personal care DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-28 US disclosed
US-9828335-B2 Nitrone compounds and their use in personal care DOW GLOBAL TECHNOLOGIES LLC (US) 2017-11-28 US disclosed
US-9796667-B2 Nitrone compounds and their use in personal care DOW GLOBAL TECHNOLOGIES LLC (US) 2017-10-24 US disclosed
US-20160362361-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC 2016-12-15 US disclosed
WO-2015175310-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-11-19 WO disclosed
WO-2015175310-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-11-19 WO disclosed
WO-2015134688-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-09-11 WO disclosed
WO-2015134688-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2015-09-11 WO disclosed
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2013-02-21 US disclosed
EP-2511283-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES, N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-10-17 EP disclosed
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-03-13 US disclosed
US-6258963-B1 DRUGS, COSMETICS HAARMANN & REIMER GMBH (DE) 2001-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160362361-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE NOX1, NOX5, NOS1 POLB 469/4885BLM 2534/4885L3MBTL1 1560/4885
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations TYR, LPO, COMT POLB 483/4885BLM 3145/4885L3MBTL1 4647/4885
US-10174033-B2 N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof ADORA2A, ADORA3, ADORA1 POLB 2416/4885BLM 2005/4885L3MBTL1 710/4885
US-20130045942-A1 N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF ADORA2A, ADORA3, ADORA1 POLB 2416/4885BLM 2005/4885L3MBTL1 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.